Cargando…
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression
Chronic inflammation is a major cause of cancer worldwide. Interleukin 33 (IL-33) is a critical initiator of cancer-prone chronic inflammation; however, its induction mechanism by the environmental causes of chronic inflammation is unknown. Herein, we demonstrate that Toll-like receptor (TLR)3/4-TBK...
Autores principales: | Park, Jong Ho, Mortaja, Mahsa, Son, Heehwa, Azin, Marjan, Wang, Jun, Collier, Michael, Mandinova, Anna, Semenov, Yevgeniy, Mino-Kenudson, Mari, Demehri, Shadmehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882616/ https://www.ncbi.nlm.nih.gov/pubmed/36711701 http://dx.doi.org/10.21203/rs.3.rs-2318750/v1 |
Ejemplares similares
-
Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment
por: Huang, Mei, et al.
Publicado: (2023) -
Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
por: Azin, Marjan, et al.
Publicado: (2023) -
TSLP/dendritic cell axis promotes CD4(+) T cell tolerance to the gut microbiome
por: Messerschmidt, Jonathan L., et al.
Publicado: (2023) -
Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk
por: Johnson, Luke H., et al.
Publicado: (2022) -
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells
por: Vyas, Maulik, et al.
Publicado: (2023)